首页> 美国卫生研究院文献>Health and Quality of Life Outcomes >Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States

【2h】

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States

机译：用西滕昔单抗或顺铂治疗的患者的生活质量分析用于美国头部和颈部型肉瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Demographic and clinical characteristics

机译：人口统计学和临床特征

著录项

期刊名称 Health and Quality of Life Outcomes
作者
Himani Aggarwal; Rajeshwari S. Punekar; Li Li; Gebra Cuyun Carter; Mark S. Walker;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 14
原文格式 PDF
正文语种
中图分类医院、综合医院;中医院;
关键词

机译：生命质量;头部和颈部的先进鳞状细胞癌;甲酸;顺铂;放射治疗;

相似文献

外文文献
中文文献
专利

1. Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States [J] . Himani Aggarwal, Rajeshwari S. Punekar, Li Li, Health and Quality of Life Outcomes . 2020,第1期

机译：用西滕昔单抗或顺铂治疗的患者的生活质量分析，用于美国头部和颈部型肉瘤
2. Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin [J] . Head and neck: Journal for the sciences and specialities of the head and neck . 2020,第8期

机译：成对的期II试验评估甲磺酸的甲磺酸和放射治疗，HPV相关的口咽癌和患者的头部和颈部的型肉瘤和颈部的型头颈癌
3. Comparative Effectiveness of Cetuximab or Cisplatin With Concomitant Radiation for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck: A Population-Based Analysis [J] . Xiang M., Holsinger F. C., Chen M. M., International Journal of Radiation Oncology, Biology, Physics . 2018,第5期

机译：西妥昔单抗或顺铂的比较疗效，伴随辐射对头部和颈部型鳞状细胞癌：基于人群的分析
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. The prognostic potential of the epidermal growth factor receptor and nuclear factor kappa B pathways and associated therapeutic strategies in patients with squamous cell carcinoma of the head and neck. [D] . Wirth, Pamela Susan. 2010

机译：表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
6. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab [O] . David I. Rosenthal, Paul M. Harari, Jordi Giralt, -1

机译：IMCL-9815 III期注册试验中人乳头瘤病毒和p16状态与结局的关系接受或不接受西妥昔单抗的放疗治疗头颈部局部区域性咽咽鳞状细胞癌
7. (OA36) Comparative Effectiveness and Toxicity of Cetuximab or Cisplatin With Concurrent Radiation for Locoregionally Advanced Squamous Cell Carcinoma of The Head And Neck: A Population-Based Analysis [O] . Michael Xiang, Floyd Christopher Holsinger, Michelle Chen, 2018

机译：（oa36）西妥昔单抗或顺铂的比较效果和毒性，对头部和颈部型肉瘤的同时辐射：基于人群的分析

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅